Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Cymer (CYMI) -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Aloha who wrote (17333)	5/4/1998 5:14:00 PM
From: Yakov Lurye	Read Replies (1) \| Respond to of 25960

[Off Topic] John Bloxom posted on this thread about ENMD about 2 months ago, when they first published a report in "Nature". Congratulations, John! I hope your invesment in CYMI will work out the same way :) Y.

To: Mr. Aloha who wrote (17333)	5/4/1998 5:22:00 PM
From: Zeev Hed	Read Replies (3) \| Respond to of 25960

Aloha, for a change, we agree. The market is fractionated with value stock with good prospects lingering (CYMI and few other semis just as examples) while the mania hit the ENMD and KTEL's. I think that people do not realize that to justify $80/share, one needs to have visibility of $1 Billion five years hence. It will take at least five years to get through the phase III clinical trial (and that only if they get acceleration, they are not starting Phase I for the next 12 to 18 months, they do not even have an INDA filed, and certainly not authorized). Then, Bristol Myers will get most of the sales (still very nice profits if everything goes right, but the wary, watch Mr Murphy). Zeev